LIM
VNRX icon

Lagoda Investment Management’s VolitionRx Ltd VNRX Stock Holding History

Lagoda Investment Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Buy
807,450
+234,270
+41% +$1.12M 2.01% 16
2025
Q4 		$2.93M Sell
573,180
-51,170
-8% -$389K 1.7% 18
2025
Q3 		$8.48M Buy
624,350
+39,100
+7% +$520K 4.8% 11
2025
Q2 		$8.9M Buy
585,250
+75,550
+15% +$833K 5.04% 9
2025
Q1 		$5.81M Buy
509,700
+130,900
+35% +$1.56M 3.7% 13
2024
Q4 		$4.55M Buy
378,800
+74,050
+24% +$993K 2.46% 14
2024
Q3 		$3.66M Buy
304,750
+32,850
+12% +$422K 2.1% 16
2024
Q2 		$3.29M Buy
271,900
+18,238
+7% +$267K 1.89% 16
2024
Q1 		$3.84M Buy
253,662
+67,232
+36% +$1.32M 2.36% 13
2023
Q4 		$2.67M Sell
186,430
-7,713
-4% -$113K 1.82% 16
2023
Q3 		$2.68M Sell
194,143
-2,313
-1% -$57.2K 1.76% 16
2023
Q2 		$5.46M Buy
196,456
+7,684
+4% +$253K 3.85% 10
2023
Q1 		$7.21M Buy
188,772
+1,020
+0.5% +$42.7K 5.13% 7
2022
Q4 		$9.12M Buy
187,752
+24,915
+15% +$967K 6.16% 3
2022
Q3 		$4.43M Sell
162,837
-8,678
-5% -$328K 3.15% 15
2022
Q2 		$7.03M Buy
171,515
+2,003
+1% +$101K 4.66% 9
2022
Q1 		$10.2M Buy
169,512
+5,316
+3% +$301K 5.5% 7
2021
Q4 		$10.3M Buy
164,196
+12,029
+8% +$821K 4.89% 9
2021
Q3 		$9.43M Buy
152,167
+15,767
+12% +$999K 4.7% 12
2021
Q2 		$8.97M Buy
136,400
+2,719
+2% +$184K 4.18% 12
2021
Q1 		$10.1M Buy
133,681
+6,307
+5% +$541K 5.04% 8
2020
Q4 		$9.91M Buy
127,374
+8,719
+7% +$600K 5.34% 9
2020
Q3 		$7.62M Buy
118,655
+9,468
+9% +$644K 5.66% 8
2020
Q2 		$8.49M Buy
109,187
+16,930
+18% +$1.22M 7.08% 7
2020
Q1 		$5.74M Buy
92,257
+1,332
+1% +$111K 6.8% 8
2019
Q4 		$8.62M Buy
90,925
+42
+0% +$4.36K 8.39% 5
2019
Q3 		$10.2M Sell
90,883
-6,296
-6% -$501K 12.02% 1
2019
Q2 		$6.1M Buy
97,179
+2,106
+2% +$136K 7.07% 8
2019
Q1 		$6.18M Buy
95,073
+12,887
+16% +$719K 7.86% 7
2018
Q4 		$2.98M Sell
82,186
-8,522
-9% -$406K 4.96% 11
2018
Q3 		$4.7M Sell
90,708
-65,080
-42% -$2.68M 1.96% 19
2018
Q2 		$6.23M Sell
155,788
-3,472
-2% -$155K 2.59% 16
2018
Q1 		$7.64M Sell
159,260
-16,588
-9% -$970K 2.88% 15
2017
Q4 		$10.3M Buy
175,848
+8,010
+5% +$469K 3.94% 11
2017
Q3 		$8.83M Buy
167,838
+10,053
+6% +$590K 3.19% 11
2017
Q2 		$11.2M Buy
157,785
+10,831
+7% +$781K 4.27% 10
2017
Q1 		$11.8M Sell
146,954
-6,766
-4% -$599K 4.59% 11
2016
Q4 		$14.1M Buy
153,720
+7,345
+5% +$659K 4.83% 11
2016
Q3 		$15.5M Buy
146,375
+65,311
+81% +$5.07M 4.67% 12
2016
Q2 		$5.11M Buy
81,064
+447
+0.6% +$30.8K 1.9% 17
2016
Q1 		$5.72M Buy
+80,617
New +$6.05M 1.87% 17

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lagoda Investment Management's VNRX Position: Q1 2026 in Review

Lagoda Investment Management increased its VolitionRx Ltd (VNRX) stake by 41% in Q1 2026, buying an estimated $1.12M and bringing the position to 807,450 shares worth $3.26M. The position accounts for 2.01% of the portfolio, ranked #16.

Lagoda Investment Management first reported a position in VNRX in Q1 2016 and has held it in 41 quarters since. The position peaked at $15.5M in Q3 2016. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Lagoda Investment Management held 807,450 shares of VolitionRx Ltd worth $3.26M as of Q1 2026.
  • Lagoda Investment Management bought 234,270 VolitionRx Ltd shares in Q1 2026, an estimated $1.12M.
  • VolitionRx Ltd made up 2.01% of Lagoda Investment Management's portfolio in Q1 2026, its #16 holding.
  • Lagoda Investment Management first reported a position in VolitionRx Ltd in Q1 2016 and has held it in 41 quarters since.
  • Lagoda Investment Management's VolitionRx Ltd position peaked at $15.5M in Q3 2016.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Lagoda Investment Management's 13F filing for Q1 2026, filed 15 May 2026.